Treatment with the gene for VEGF, a growth stimulating chemical, can dramatically improve the survival of mice with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, new research indicates.
Treatment with the gene for VEGF, a growth stimulating chemical, can dramatically improve the survival of mice with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, new research indicates.
